Medical Care Technologies Inc. CEO Dr. Alicia Reynolds and a five-member technology team are attending the Consumer Electronics Show 2026 in Las Vegas this week, engaging in over 15 scheduled one-on-one meetings with wearable device manufacturers, telehealth platform providers and AI research firms. The delegation is showcasing MDCE’s proprietary VitalGuard™ sensor integration and exploring partnership agreements to integrate its wellness analytics into next-generation smartwatches. The company expects to secure at least two memorandum of understanding agreements by the end of the event, which could extend its distribution network into North America and Europe, potentially adding 200,000 new users to its AI wellness application portfolio within 12 months.

On January 5 in Mesa, Arizona, MDCE announced successful completion of internal readiness testing for its AI-powered skin lesion pre-screening mobile application. The trial involved 1,200 anonymized dermatology images covering 18 lesion types, achieving 94.7% sensitivity and 89.3% specificity against dermatologist diagnoses. The app’s risk-awareness module delivered real-time categorization within two seconds per image. With regulatory documentation now submitted to the FDA, the company plans a phased public rollout in Q3 2026 and projects 50,000 downloads in the first quarter post-launch, targeting primary care providers and consumer health clinics.